EGFRm Advanced Non-Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch EGFRm Advanced Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC Patients (NCT06279728) | Daiichi Sankyo |
Track EGFRm Advanced Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.